Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Shares Outstanding (2019 - 2026)

Immatics (IMTX) posted Shares Outstanding (Entity) of $134.1 million for Q4 2025, up 10.29% sequentially from $121.6 million in Q3 2025, and up 10.3% YoY from $121.6 million in Q4 2024.

Analysis

Immatics (IMTX) Shares Outstanding (2019 - 2026) Analysis & Trends

Immatics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $134.1 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 10.3% year-over-year to $134.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $134.1 million (up 10.3% YoY) and the FY2025 annual result came in at $134.1 million, up 10.3% from the prior year.
  • Shares Outstanding (Entity) climbed to $134.1 million in Q4 2025 per IMTX's latest filing, from $121.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $134.1 million in Q4 2025 and troughed at $62.9 million in Q1 2021.
  • A 5-year average of $88.6 million and a median of $81.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The widest YoY moves for Shares Outstanding (Entity): up 90.09% in 2021, down 0.0% in 2021.
  • Over 5 years, Shares Outstanding (Entity) stood at $62.9 million in 2021, then increased by 21.84% to $76.7 million in 2022, then grew by 10.42% to $84.7 million in 2023, then jumped by 43.58% to $121.6 million in 2024, then gained by 10.3% to $134.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $134.1 million, $121.6 million, and $121.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Immatics 1.17 Bn 711.21 Mn - 122.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122.35 Mn
Mar 31, 2026 122.35 Mn
Dec 31, 2025 122.35 Mn
Sep 30, 2025 105.74 Mn
Jun 30, 2025 105.74 Mn
Mar 31, 2025 105.74 Mn
Dec 31, 2024 105.74 Mn
Sep 30, 2024 103.11 Mn
Jun 30, 2024 103.07 Mn
Mar 31, 2024 98.74 Mn
Dec 31, 2023 80.55 Mn
Sep 30, 2023 67.22 Mn
Jun 30, 2023 67.22 Mn
Mar 31, 2023 67.22 Mn
Dec 31, 2022 67.22 Mn
Sep 30, 2022 62.91 Mn
Jun 30, 2022 62.91 Mn
Mar 31, 2022 62.91 Mn
Dec 31, 2021 62.91 Mn
Sep 30, 2021 48.00 Mn